An exploratory genome-wide association study of leprosy susceptibility genes in a Thai cohort
คำสำคัญ:
Leprosy, Genome-wide association studies, GWASบทคัดย่อ
Leprosy is a chronic granulomatous infectious disease caused by Mycobacterium leprae. Although candidate gene studies have explored genetic susceptibility to leprosy, only a limited number of genomic loci have been independently replicated. In contrast, genome-wide association studies (GWAS) have provided clear evidence that host genetic factors—varying across different ethnic populations—play a critical role in determining human susceptibility to infection and in influencing the progression of infectious diseases. We performed genome-wide association study involving 344 individuals with leprosy - 103 with paucibacillary form and 241 multibacillary form - and 200 control individuals, using the Illumina Ommi express platform. This study highlights a potential genome-wide association signal for leprosy on chromosome 18 (18q21.33–18q22.1) supported by suggestive evidence (P-values<1×10-5). Within this region, the lead variant rs9949621 demonstrated the strongest association (P-values<4.75×10-6, Odds Ratio [OR] = 0.53, 95% Confidence Interval [CI] = 0.40-0.70) and is located near the HMSD gene. The association peak extended across a broader region encompassing several SERPIN family genes (SERPINB2, SERPINB10, HMSD, and SERPINB8), where multiple single nucleotide polymorphisms (SNPs) consistently showed P-values below 5.0×10−5. Collectively, this suggests that variants within this gene cluster may influence genetic susceptibility to leprosy. Importantly, all associated SNPs appeared to confer a protective effect, as the minor alleles were more frequent in controls than in cases, indicating reduced disease risk in carriers. Our genome-wide association study (GWAS) suggests a potential novel link between HMSD and several genes within the SERPIN family and susceptibility to leprosy in the Thai population. While these results highlight a promising genetic association, they will need to be confirmed through independent replication studies and supported by functional investigations. Additional high-resolution genotyping or sequencing analyses will also be necessary to refine these findings and clarify their biological significance.
เอกสารอ้างอิง
Hastings RC, editor. Leprosy. Edinburgh: Churchill Livingstone; 1985. p. 31-36, 189-194, 322-323.
McDougall AC, Jopling WH. Handbook of leprosy. 5th ed. Oxford: Heinemann Professional Publishing; 1988.
World Health Organization. Global leprosy (Hansen disease) update, 2024: Beyond zero cases – what elimination of leprosy really means. Wkly Epidemiol Rec. 2025;100(37):365-384.
Department of Disease Control, Ministry of Public Health. สถานการณ์โรคเรื้อนในประเทศไทย ปี พ.ศ. 2567 [Internet]. Nonthaburi: Department of Disease Control; 2024 [cited 2025 Aug 28]. Available from: https://rajpracha.ddc.moph.go.th/Rpsi_pages/Nonthaburi/satus_lep.html.
Siddiqui MR, Meisner S, Tosh K, Balakrishnan K, Ghei S, Fisher SE, et al. A major susceptibility locus for leprosy in India maps to chromosome 10p13. Nat Genet. 2001;27(4):439-41.
Tosh K, Meisner S, Siddiqui MR, Balakrishnan K, Ghei S, Golding M, et al. A region of chromosome 20 is linked to leprosy susceptibility in a South Indian population. J Infect Dis. 2002;186(8):1190-3.
Mira MT, Alcaïs A, Van Thuc N, Thai VH, Huong NT, Ba NN, et al. Chromosome 6q25 is linked to susceptibility to leprosy in a Vietnamese population. Nat Genet. 2003;33(3):412-5.
Zhang FR, Huang W, Chen SM, Sun LD, Liu H, Li Y, et al. Genomewide association study of leprosy. N Engl J Med. 2009;361(27):2609-18.
Fava VM, Dallmann-Sauer M, Orlova M, Correa-Macedo W, Van Thuc N, Thai VH, et al. Deep resequencing identifies candidate functional genes in leprosy GWAS loci. PLoS Negl Trop Dis. 2021;15(12):e0010029.
Gilchrist JJ, Auckland K, Parks T, Mentzer AJ, Goldblatt L, Naranbhai V, et al. Genome-wide association study of leprosy in Malawi and Mali. PLoS Pathog. 2022;18(9):e1010312.
Chaichoompu K, Abegaz F, Tongsima S, Shaw PJ, Sakuntabhai A, Pereira L, et al. IPCAPS: an R package for iterative pruning to capture population structure. Source Code Biol Med. 2019;14:2.
Lippert C, Listgarten J, Liu Y, Kadie CM, Davidson RI, Heckerman D. FaST linear mixed models for genome-wide association studies. Nature Methods. 2011;8(10):833-5.
Boughton AP, Welch RP, Flickinger M, VandeHaar P, Taliun D, Abecasis GR, et al. LocusZoom.js: interactive and embeddable visualization of genetic association study results. Bioinformatics. 2021 Sep;37(18):3017-3018.
Leblond J, Laprise MH, Gaudreau S, Grondin F, Kisiel W, Dubois CM. The serpin proteinase inhibitor 8: an endogenous furin inhibitor released from human platelets. Thromb Haemost. 2006;95(2):243-52.
Pigors M, Sarig O, Heinz L, Plagnol V, Fischer J, Mohamad J, et al. Loss-of-Function Mutations in SERPINB8 Linked to Exfoliative Ichthyosis with Impaired Mechanical Stability of Intercellular Adhesions. Am J Hum Genet. 2016;99(2):430-6.
Przygodzka P, Ramstedt B, Tengel T, Larsson G, Wilczynska M. Bomapin is a redox-sensitive nuclear serpin that affects responsiveness of myeloid progenitor cells to growth environment. BMC Cell Biol. 2010;11:30.
Kawase T, Akatsuka Y, Torikai H, Morishima S, Oka A, Tsujimura A, et al. Alternative splicing due to an intronic SNP in HMSD generates a novel minor histocompatibility antigen. Blood. 2007;110(3):1055-63.
Medcalf RL, Stasinopoulos SJ. The undecided serpin. The ins and outs of plasminogen activator inhibitor type 2. Febs j. 2005;272(19):4858-67.
Kruithof EK, Baker MS, Bunn CL. Biological and clinical aspects of plasminogen activator inhibitor type 2. Blood. 1995;86(11):4007-24.
Perazzoli S, Fiuza MF, De Moraes PC, Heck R, Vianna FS, Bonamigo RR. Prevalence of genetic variants in SERPINB2 and PKNOX1 genes in erythema nodosum leprosum patients from southern Brazil. J Infect Dev Ctries. 2025;19(7):1083-8.
ดาวน์โหลด
เผยแพร่แล้ว
รูปแบบการอ้างอิง
ฉบับ
ประเภทบทความ
สัญญาอนุญาต
ลิขสิทธิ์ (c) 2026 มหาวิทยาลัยพะเยา

อนุญาตภายใต้เงื่อนไข Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
ผู้นิพนธ์ต้องรับผิดชอบข้อความในบทนิพนธ์ของตน มหาวิทยาลัยพะเยา ไม่จำเป็นต้องเห็นด้วยกับบทความที่ตีพิมพ์เสมอไป ผู้สนใจสามารถคัดลอก และนำไปใช้ได้ แต่จะต้องขออนุมัติเจ้าของ และได้รับการอนุมัติเป็นลายลักษณ์อักษรก่อน พร้อมกับมีการอ้างอิงและกล่าวคำขอบคุณให้ถูกต้องด้วย

